申请人:Bayer Aktiengesellschaft
公开号:US05371300A1
公开(公告)日:1994-12-06
The present invention relates to novel chloro-(2-halogeno-1-fluoromethyl-ethoxy)-methanes and to their preparation. The novel compounds can be used as intermediates for the preparation of biologically active substituted benzimidazoles.
本发明涉及新型的
氯-(2-卤代-1-
氟甲基-乙氧基)-
甲烷化合物及其制备方法。这些新型化合物可以用作制备
生物活性取代
苯并咪唑的中间体。